Managing Adverse Effects of Scopolamine

Management Strategy for Adverse Effects

The American College of Physicians recommends glycopyrrolate as the first-line alternative to scopolamine due to its effectiveness and minimal central nervous system effects, particularly in elderly patients 1
Glycopyrrolate does not effectively cross the blood-brain barrier, making it less likely to cause sedation, drowsiness, or delirium, and is particularly beneficial in elderly patients or those with cognitive impairment 1
The National Comprehensive Cancer Network recommends atropine as a second-line option if glycopyrrolate is ineffective, at a dose of 0.5-1 mg subcutaneous, IM, IV, or sublingual every 4-6 hours as needed 2
Hyoscyamine is another alternative for managing secretions, at a dose of 0.125 mg PO/ODT/SL every 4 hours as needed, maximum 1.5 mg/day 1

Ensuring adequate hydration is recommended for patients experiencing dry mouth 1
The National Comprehensive Cancer Network suggests using artificial saliva products or sugar-free candies/gum to manage dry mouth 3
For urinary retention, monitoring urinary output, especially in elderly patients, and considering intermittent catheterization if necessary, is recommended 1, 2

A multimodal approach with other antiemetic classes is recommended when using scopolamine for prevention of nausea and vomiting 4
Combining scopolamine with drugs from different classes, such as dexamethasone or ondansetron, may allow for lower doses of each medication and reduce the risk of anticholinergic side effects 4

Monitoring for common anticholinergic side effects, including dry mouth, urinary retention, constipation, and blurred vision, is recommended 1
Ensuring adequate hydration status while using anticholinergic medications is also recommended 1